5 Dec 2019 - The Edge Markets
SINGAPORE (Dec 5): iX Biopharma has been awarded a cannabis manufacture license from the Australian Office of Drug Control to manufacture and supply extracts and tinctures of cannabis and cannabis resins. The specialty pharmaceutical company’s wholly-owned subsidiary, iX Syrinx, operates a TGA cGMP certified ...
sgx:42c